Search Results 1-10 of 16009 for Irinotecan

  1. Irinotecan (Intravenous Route) Description and Brand Names - Mayo Clinic

    Irinotecan belongs to the group of medicines called antineoplastics (cancer medicines). It interferes with the growth of cancer cells, which are eventually ...

  2. Irinotecan (Intravenous Route) Precautions - Mayo Clinic

    Irinotecan can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of ...

  3. Irinotecan (Intravenous Route) Side Effects - Mayo Clinic

    Anxiety · black, tarry stools · blood in the urine or stools · blurred vision · changes in skin color · chest pain or discomfort · chest tightness or heaviness ...

  4. Irinotecan Liposome (Intravenous Route) Description and Brand Names - Mayo Clinic

    Descriptions. Irinotecan liposome injection is used in combination with other medicines (eg, fluorouracil, leucovorin, and oxaliplatin) as first-line treatment ...

  5. Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery - Mayo Clinic

    Participation eligibility · Patient has an in-range INR (usually 2-3) on a stable dose of warfarin =< 14 days or is on a stable dose of low molecular weight ...

  6. Irinotecan (Intravenous Route) Proper Use - Mayo Clinic

    Irinotecan often causes nausea and vomiting. However, it is very important that you continue to receive this medicine even if you begin to feel ill.

  7. Irinotecan Liposome (Intravenous Route) Side Effects - Mayo Clinic

    More common · Bleeding gums · confusion · coughing up blood · decreased urination · diarrhea (severe) · difficulty in swallowing · dizziness · dry mouth ...

  8. Irinotecan (Intravenous Route) Before Using - Mayo Clinic

    Geriatric. Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of irinotecan injection in ...

  9. Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients with Refractory or Relapsed Neuroblastoma - Mayo Clinic

    Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients with Refractory or Relapsed ...

  10. S1406 A Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer - Mayo Clinic

    Irinotecan hydrochloride and vemurafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such ...